September 29, 2012 | The Lancet
Sabin Executive Vice President, Dr. Ciro de Quadros recently co-authored the following correspondence, which appeared in the September 29 edition of the Lancet.
Reducing the global burden of congenital rubella syndrome
Congenital Rubella Syndrome (CRS) causes severe growth and mental retardation, deafness and other developmental problems in developing fetuses. CRS is the result of infection by rubella (also known as German Measles) during the first trimester of pregnancy and, while the effects on the mother can be very mild, the effects on the developing fetus can be devastating. Though the burden of CRS is not well documented, the WHO estimates that in developing countries alone 100,000 cases of CRS occur each year.